SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000930413-22-000789
Filing Date
2022-04-21
Accepted
2022-04-21 16:15:24
Documents
8

Document Format Files

Seq Description Document Type Size
1 c102797_defa14a.htm DEFA14A 34195
2 GRAPHIC x18_c102797x2x1.jpg GRAPHIC 49388
3 GRAPHIC x18_c102797x2x2.jpg GRAPHIC 5163
4 GRAPHIC x18_c102797x2x3.jpg GRAPHIC 3186
5 GRAPHIC x18_c102797x2x4.jpg GRAPHIC 7360
6 GRAPHIC x18_c102797x2x5.jpg GRAPHIC 6871
7 GRAPHIC x18_c102797x3x1.jpg GRAPHIC 1098
8 GRAPHIC x18_c102797x3x1a.jpg GRAPHIC 1098
  Complete submission text file 0000930413-22-000789.txt   138435
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19034 | Film No.: 22841593
SIC: 2834 Pharmaceutical Preparations